Roche Will Donate Hemophilia A Drug to Developing Countries
Roche will donate its new hemophilia A drug emicizumab-kxwh to the World Hemophilia Federation (WHF) Humanitarian Aid Program. Roche joins other companies – including...
New Drug Approvals in Nonmalignant Hematology
In 2018, the U.S. Food and Drug Administration (FDA) set a record for the number of approvals for new therapies – or new indications...
China First to Approve Oral Drug to Stimulate Erythropoiesis
China’s National Medical Products Administration approved the oral anemia drug roxadustat, well before regulators in the U.S. or Europe have issued decisions. The hypoxia-inducible...
FDA Approves New Hemophilia A Drug
The FDA has approved emicizumab-kxwh as prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A...
Emicizumab Prophylaxis Reduces Bleeding Events in Hemophilia A Without Inhibitors
Treatment with emicizumab was associated with lower bleeding rates, compared with no prophylaxis, in patients with hemophilia A without inhibitors, according to findings from...
No Added Benefit When Hydroxyurea Is Combined With Aspirin in Middle-Aged Patients With Essential...
Cytoreductive treatment with hydroxyurea has been shown to reduce the risk of thrombosis in patients with essential thrombocythemia (ET) and high-risk features, which include...
FDA Approves New Treatment for Hemophilia
The U.S. Food and Drug Administration (FDA) approved BAY94-9027, or antihemophilic factor (recombinant), PEGylated-aucl, for the prophylactic treatment of adults and adolescents (≥12 years)...
Evaluating Twice-Yearly Denosumab for Transfusion-Dependent, Thalassemia-Induced Osteoporosis
Treatment with twice-yearly denosumab improved spinal bone mineral density (BMD) compared with placebo in patients with transfusion-dependent thalassemia (TDT)–induced osteoporosis, according to results of...
How to Treat Anemia in a Patient Who Refuses Transfusions for Religious Reasons
This month, Neil A. Zakai, MD, discusses how to treat anemia in a patient who refuses packed red blood cells.
And don't forget to check out...
How to Treat Anemia in a Patient Who Refuses Transfusions for Religious Reasons
Here’s how readers responded to a You Make the Call question about a Jehovah's Witness patient with stage IV uterine cancer, a uterine abscess,...
Current Issue
February 2019, Volume 5, Issue 3
This issue features a look at the unique challenges of developing treatments for orphan diseases, more coverage of the 2018 ASH annual meeting, and more.
